With India planning a massive vaccination campaign against Covid-19, each state has been advised to set up special centers in each block to deal with possible adverse events after vaccination, ranging from allergic reactions to high fever to more serious problems that one another Developing day later you can get the shot administered.
The authorities in 633 districts were advised to set up at least one such special center in each block, equipped with doctors and paramedical staff to deal with the adverse events. The center has provided detailed instructions to states on infection prevention and control during vaccination and treatment of minor, severe, and severe AEFIs.
Read: Center Says Covid-19 Cases, Deaths In India To Decline; warns of any negligence
“We cannot deny the possibility of an adverse event at the beginning of the Covid-19 vaccination. In countries where vaccination has already started, particularly the UK, adverse events occurred on the first day. It is important that states and Union territories also prepare for this, ”said Union Health Minister Rajesh Bhushan.
Each vaccination site has been connected to such a unit so that the recipient can be quickly taken to a management center in the event of a serious side effect.
“Our existing AEFI (Post-Immunization Adverse Events) system is aimed at children and women. Most of these vaccines are administered in hospitals. So while it is an adult vaccine, it must have a separate AEFI management unit as Covid-19 give vaccines are new vaccines based on different types of platforms, ”said Vinod Paul, NITI Ayog member and former professor at AIIMS Delhi on Tuesday.
The center plans to vaccinate 30 Crore people initially, starting with a Crore doctor and two Crore front-line staff. While six vaccines are currently under clinical evaluation, three manufacturers have reached out to the Central Drug Standards and Control Organization for emergency approval.
Also Read: Household Savings Decline Due To Covid-19: Survey
During clinical trials in India, two such adverse events were recorded in Covid-19 vaccines manufactured by Bharat Biotech, Hyderabad and Serum Institute, Pune.
The preliminary investigation by the institutional ethics committee did not reveal any causal links between the vaccine and the side effects, and the study will continue. The regulatory authority CDSCO has been silent so far.
“Given the limited information period for (Covid-19) vaccines, there is a need to address concerns in addition to the solid evidence base for effectiveness in real time,” said Giridhar Babu, epidemiologist at Public Health Foundation of India DHExplain the importance of setting up the AEFI network.
While the daily number of new Covid-19 cases has dropped to over 22,000, India is on the verge of registering more than one Crore Covid-19 cases as the number was 99.06 lakh. The death toll is 1.43,709, of which 354 were added in the last 24 hours.